Drug intelligence / Profile preview

pilohenz

Development stage: Unknown
Lead developer: Rebrace Pharmaceuticals
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral, Topical

Overview

Pilohenz is a botanical combination product developed and marketed by Rebrace Pharmaceuticals for the management of hemorrhoids (piles) and anal fissures. The product is available in two distinct formulations: Pilohenz Tablets for oral administration, indicated for both internal and external hemorrhoids, and Pilohenz Ano Cream for topical application to treat hemorrhoids and anal fissures. As an herbal formulation, it is designed to provide symptomatic relief from the pain, swelling, and bleeding associated with anorectal disorders.

Brand names: PilohenzPilohenz Ano Cream
Other names: Pilohenz Tablets

Beyond the preview

Go deeper on pilohenz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on pilohenz.

Explore the full profile